This week in Boston Visikol will be presenting at the SBI2 conference at the Harvard Medical School’s Joseph B. Martin Conference Center on their 3Screen™ drug discovery services and how they are using high content imaging to help clients accelerate their drug discovery programs. Specifically, Visikol will discuss its 3Screen™ image analysis software for use with 3D cell culture models and how it is being applied to offer T-Cell Infiltration, Beta Cell Proliferation and antibody penetration assay services.

This year, Visikol is teaming up with InSphero at Booth 4 to show you how you can leverage 3D InSight™ Microtissues using Visikol’s high content imaging services.

2019-02-21T01:30:51-05:00

Share This Page, Choose Your Platform!

This website uses cookies to enhance the user experience. Ok